Bruker (BRKR) EBT Margin Growth (1y) (2011 - 2026)
Bruker (BRKR) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -464.00 |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 772.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 233.00 |
| 10 | Bruker | 9.24 Bn | 9.24 Bn | 379.80 Mn | -47.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.00 |
| Dec 31, 2025 | 3,812.00 |
| Sep 30, 2025 | 53.00 |
| Jun 30, 2025 | 23.00 |
| Mar 31, 2025 | 1,038.00 |
| Dec 31, 2024 | -5,509.00 |
| Sep 30, 2024 | -560.00 |
| Jun 30, 2024 | -952.00 |
| Mar 31, 2024 | -1,856.00 |
| Dec 31, 2023 | 7,133.00 |
| Sep 30, 2023 | -824.00 |
| Jun 30, 2023 | 5.00 |
| Mar 31, 2023 | 87.00 |
| Dec 31, 2022 | -4,419.00 |
| Sep 30, 2022 | 237.00 |
| Jun 30, 2022 | 1,876.00 |
| Mar 31, 2022 | 2,086.00 |
| Dec 31, 2021 | -2,084.00 |
| Sep 30, 2021 | 314.00 |
| Jun 30, 2021 | -1,766.00 |